Financial Data and Key Metrics Changes - For Q3 2025, revenue was $2.4 million, a slight decrease from $2.5 million in Q3 2024. For the nine months ended September 30, 2025, revenue was $6.9 million, compared to $6.6 million for the same period in 2024 [10] - Gross profit for the nine months ended September 30, 2025, was approximately $4.9 million, reflecting no material year-over-year change [10] - Operating expenses were approximately $1.1 million for Q3 2025, a reduction of over $500,000 compared to the same period last year [5][10] Business Line Data and Key Metrics Changes - In the dental segment, international sales increased year-over-year, partially offsetting a decline in domestic revenue [6] - Utilization of CompuFlow disposables rebounded slightly, indicating a re-engagement with current customers [6][8] Market Data and Key Metrics Changes - The company has a market share of approximately 1.5%-2% in both domestic and international markets, indicating significant room for growth [17] - The company is focusing on expanding its commercial coverage footprint in key jurisdictions like New Jersey, Texas, and Florida [8][24] Company Strategy and Development Direction - The company is executing a transformational strategy focused on streamlining operations, strengthening commercial execution, and advancing reimbursement strategies for CompuFlow [5][12] - The addition of Dr. Dawood Syed to the board aims to enhance clinical and payer expertise, supporting the strategy for broader adoption within hospital systems [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's technology and emphasized the need for a structured approach to sales and reimbursement to ensure sustainable growth [40][41] - The focus remains on disciplined execution, operational excellence, and building value for shareholders, customers, and patients [12][54] Other Important Information - As of September 30, 2025, the company had cash and cash equivalents of approximately $1.3 million and working capital of approximately $3.1 million [11] - The company is considering establishing a bonded warehouse in the U.S. to mitigate potential tariff impacts [29] Q&A Session Summary Question: How to convince dental clinics to invest in new equipment? - Management acknowledged the challenge and emphasized the need for better education and marketing to increase awareness of the product's benefits [15][17] Question: What is the plan for broader commercialization of CompuFlow? - The focus is on a few key states and jurisdictions, with plans to collect data meticulously to support Medicare reimbursement [21][22] Question: How is the salesforce structured? - The company plans to ramp up the salesforce and is considering adding reimbursement specialists to enhance sales efforts [31][32] Question: Is there a seasonality pattern in sales? - Management indicated that the business is steady without significant seasonal fluctuations, expecting a similar performance in Q4 [33] Question: What is the current cash position and need for capital? - The company has sufficient cash to operate for several quarters and is looking for opportunities to improve its financial position if necessary [50]